IGF2BP3 and urinary bladder carcinoma: Compared with IGF2BP3, which has been widely reported in a variety of tumors such as breast, liver, and gastrointestinal tract tumors, pancreatic cancer, and lung cancer [138], knowledge on its role in bladder cancer is limited.